Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112222595 | 11222259 | 5 | F | 20041108 | 20160816 | 20150626 | 20160825 | EXP | DK-DKMA-ADR 23030944 | DK-TEVA-572223ISR | TEVA | 29.69 | YR | M | Y | 0.00000 | 20160825 | LW | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112222595 | 11222259 | 1 | PS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 165 MG/M2 DAY 1+2+3, EVERY 3 WEEKS 3 TIMES | U | U | 74284 | 1 | DF | ||||||
| 112222595 | 11222259 | 2 | SS | CISPLATIN ^HOSPIRA^ | CISPLATIN | 1 | Intravenous (not otherwise specified) | 50 MG/M2 , DAY 1+2 EVERY 3 WEEKS 3 TIMES. | U | U | 0 | 1 | DF | SOLUTION FOR INFUSION | Q3W | ||||
| 112222595 | 11222259 | 3 | SS | BLEOMYCIN ^BAXTER^ | BLEOMYCIN SULFATE | 1 | Intravenous (not otherwise specified) | U | U | 0 | 30000 | IU | INJECTION | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112222595 | 11222259 | 1 | Testis cancer |
| 112222595 | 11222259 | 2 | Testis cancer |
| 112222595 | 11222259 | 3 | Testis cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112222595 | 11222259 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112222595 | 11222259 | Anaemia | |
| 112222595 | 11222259 | Back pain | |
| 112222595 | 11222259 | Blood creatinine increased | |
| 112222595 | 11222259 | Chronic kidney disease | |
| 112222595 | 11222259 | Dizziness | |
| 112222595 | 11222259 | Fatigue | |
| 112222595 | 11222259 | Haemorrhoids | |
| 112222595 | 11222259 | Hypertension | |
| 112222595 | 11222259 | Musculoskeletal discomfort | |
| 112222595 | 11222259 | Renal impairment | |
| 112222595 | 11222259 | Vertigo | |
| 112222595 | 11222259 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112222595 | 11222259 | 1 | 20040706 | 0 | ||
| 112222595 | 11222259 | 2 | 20040706 | 0 | ||
| 112222595 | 11222259 | 3 | 20040706 | 2004 | 0 |